MRKR Marker Therapeutics, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
03:58
Jan 06
Jan 06
Positive pancreatic cancer data for MRKR
Author highlights positive Baylor study data showing 84.6% disease control and median OS 14.1 months in pancreatic cancer, implying a bullish signal for Marker Therapeutics. The safety profile and T-cell persistence support the clinical benefit.
MED
About MRKR Investor Commentary
Across the available history and selected sources, Buzzberg tracks MRKR (Marker Therapeutics, Inc.) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: u/Chance-Ocelot6436.